Search
                    Coronary Heart Disease Clinical Trials
A listing of 4  Coronary Heart Disease  clinical trials  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            1 - 4 of 4
        
        
    
                There are currently 4 active clinical trials seeking participants for Coronary Heart Disease research studies. The states with the highest number of trials for Coronary Heart Disease participants are Florida, California, Texas and Ohio.
            
                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    
                
                                    Project 3: ACHIEVE- CHD
                                
            
            
        Recruiting
                            
            
                This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic c...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 40 years and 75 years
            Trial Updated:
                07/09/2025
            
            Locations: University Hospitals Cleveland Medical Center, Cleveland, Ohio         
        
        
            Conditions: Coronary Heart Disease
        
            
        
    
                
                                    Thiamine Intervention and Coronary Artery Bypass Grafting
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to gain a better understanding of the association between brain changes and cognitive deficits in coronary heart disease (CHD) patients undergoing coronary artery bypass grafting (CABG) and whether a low-cost thiamine intervention can be used to reduce post-CABG cognitive issues in CHD subjects.             
        
        
    Gender:
                ALL
            Ages:
                Between 60 years and 80 years
            Trial Updated:
                07/30/2025
            
            Locations: UCLA, Los Angeles, California         
        
        
            Conditions: Coronary Heart Disease, Coronary Artery Bypass Grafting
        
            
        
    
                
                                    Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients
                                
            
            
        Recruiting
                            
            
                Developed nations worldwide are currently enduring a health crisis, as chronic diseases continue to decrease quality of life and promote additional disease states or even death for much of the population. Rural populations are at a particular disadvantage, as they lack access to health clubs, wellness programs and similar resources that are more available in urban areas. Although pharmaceutical therapies have continued to show therapeutic advancements, the rates of disease onset and death from c...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 64 years
            Trial Updated:
                07/21/2025
            
            Locations: West Virginia School of Osteopathic Medicine, Lewisburg, West Virginia         
        
        
            Conditions: Obesity, Hyperlipidemias, Polycystic Ovary Syndrome, Hypertension, Coronary Heart Disease, Heart Failure, Depression, Anxiety, Type II Diabetes, Metabolic Syndrome
        
            
        
    
                
                                    Cardiac Markers in Depressed Patients With Coronary Heart Disease - R01HL147862
                                
            
            
        Recruiting
                            
            
                Depression doubles the risk of death in patients with coronary heart disease (CHD), but so far, there is insufficient evidence that we can reduce the risk of death by treating depression. This study will investigate the cardiac risk markers that are associated with depression symptoms that remain despite treatment, and identify potential targets for their treatment. The results of the study will inform the development of more effective interventions to improve both depression and survival in pat...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                03/20/2024
            
            Locations: Washington University, Saint Louis, Missouri         
        
        
            Conditions: Coronary Heart Disease, Depression
        
            
        
    1 - 4 of 4
            
            
        